Archives: News
-

AICO welcomes Vadim Sokolov, PhD, Cofounder & Chief Technology Officer
—
by
AICO today announced that Vadim Sokolov, PhD, has joined the company as Cofounder and Chief Technology Officer. In this role, Dr. Sokolov will lead the architectural design and development of AICO’s next-generation clinical operating system to transform the execution of clinical trials through ontology and agentic AI. Dr. Sokolov is a well-recognized thought leader in…
-
AICO Welcomes Industry Veteran David Lew as Clinical Operations Expert
—
by
AICO Welcomes Industry Veteran David Lew as Clinical Operations Expert We’re excited to announce that David Lew, MS, MBA, has joined AICO as a Clinical Operations Expert. David brings over 20 years of experience across global clinical research roles at leading organizations, including Covance, PPD, IQVIA, and Velocity Clinical Research, spanning both CROs and site…
-
FDA Launches Agency-Wide AI Tool
—
by
FDA Launches Agency-Wide AI Tool “The U.S. Food and Drug Administration has rolled out “Elsa,” a secure, agency-wide generative-AI tool built in GovCloud to help reviewers, inspectors, and other staff swiftly read, write, summarize, and code regulatory data. Announced on June 2, 2025, Elsa is already expediting clinical-protocol reviews, condensing adverse-event summaries, and even pinpointing…
-
AICO Global Files Provisional Patent
—
by
AICO Global Files Provisional Patent for AI Agent System Transforming Clinical Trial Operations, June 14, 2025 AICO Global has submitted a provisional patent application to the United States Patent and Trademark Office (USPTO) for its artificial intelligent agent system for clinical trial operations management. This filing marks a major milestone in advancing AI solutions for…
-

AICO Global Joins Nvidia Inception Program
—
by
AICO Global Joins Nvidia Inception Program, August 8, 2025 AICO Global has been accepted into NVIDIA Inception, a program that helps AI startups accelerate product development and scale. The milestone aligns with our mission to build an Agent AI system that streamlines end-to-end clinical trial operations. As a member, we gain access to technical resources…